HEPATIC FUNCTION ABNORMAL
Clinical trials for HEPATIC FUNCTION ABNORMAL explained in plain language.
Never miss a new study
Get alerted when new HEPATIC FUNCTION ABNORMAL trials appear
Sign up with your email to follow new studies for HEPATIC FUNCTION ABNORMAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver study tests safety of fexinidazole in 21 volunteers
Knowledge-focused CompletedThis study looked at how the drug fexinidazole, used for sleeping sickness, is processed by the body in people with mild or moderate liver impairment compared to those with normal liver function. Twenty-one adults took a single 1200 mg tablet, and researchers measured drug levels…
Matched conditions: HEPATIC FUNCTION ABNORMAL
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:56 UTC
-
Liver function may change how venglustat works in the body
Knowledge-focused CompletedThis early-stage study looked at how a single dose of venglustat is processed in people with mild, moderate, or severe liver problems compared to healthy adults. Twenty-six participants received one tablet and were monitored for about three weeks. The goal was to see if liver fun…
Matched conditions: HEPATIC FUNCTION ABNORMAL
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:06 UTC